147 related articles for article (PubMed ID: 2149045)
1. A clinical trial on efficacy and safety of teicoplanin in combination with beta-lactams and aminoglycosides in the treatment of severe sepsis of patients undergoing allogeneic/autologous bone marrow transplantation.
Lang E; Schmid J; Fauser AA
Br J Haematol; 1990 Dec; 76 Suppl 2():14-8. PubMed ID: 2149045
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.
Fauser AA; Lang E; Dölken G; Bross KJ; Schmid J; Sörgel F
Infection; 1991; 19(3):195-200. PubMed ID: 1832419
[TBL] [Abstract][Full Text] [Related]
3. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
[TBL] [Abstract][Full Text] [Related]
4. Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients.
Menichetti F; Del Favero A; Bucaneve G; Aversa F; Baldelli F; Felicini R; Terenzi A; Pauluzzi S
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():105-11. PubMed ID: 2965121
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
Del Favero A; Menichetti F; Guerciolini R; Bucaneve G; Baldelli F; Aversa F; Terenzi A; Davis S; Pauluzzi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1126-9. PubMed ID: 2959198
[TBL] [Abstract][Full Text] [Related]
6. Teicoplanin for therapy of gram-positive infections in neutropenic patients.
Verhagen C; De Pauw BE
Int J Clin Pharmacol Res; 1987; 7(6):491-8. PubMed ID: 2964418
[TBL] [Abstract][Full Text] [Related]
7. A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria.
Lewis P; Garaud JJ; Parenti F
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():61-7. PubMed ID: 2965133
[TBL] [Abstract][Full Text] [Related]
8. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
Lim SH; Smith MP; Goldstone AH; Machin SJ
Br J Haematol; 1990 Dec; 76 Suppl 2():41-4. PubMed ID: 2149051
[TBL] [Abstract][Full Text] [Related]
9. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
Micozzi A; Venditti M; Amadori S; Pulsoni A; Tirindelli C; Martino P
Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046
[TBL] [Abstract][Full Text] [Related]
10. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
DeJace P; Klastersky J
Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients.
Fauser AA; Lang E; Köchling G; Daschner FD
Infection; 1994; 22(4):271-5. PubMed ID: 8002087
[TBL] [Abstract][Full Text] [Related]
12. Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.
Smith CL; Milliken S; Powles R; Da Costa F; Gore M; Benjamin S; Talbot D; Ellis L; Large J; Jameson B
Br J Haematol; 1990 Dec; 76 Suppl 2():6-9. PubMed ID: 2149055
[TBL] [Abstract][Full Text] [Related]
13. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
[TBL] [Abstract][Full Text] [Related]
14. Options and limitations of teicoplanin in febrile granulocytopenic patients.
De Pauw BE; Novakova IR; Donnelly JP
Br J Haematol; 1990 Dec; 76 Suppl 2():1-5. PubMed ID: 2149042
[TBL] [Abstract][Full Text] [Related]
15. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
17. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
[TBL] [Abstract][Full Text] [Related]
18. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of severe infections: should one always administer an aminoglycoside?].
Cometta A; Baumgartner JD
Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
